Patient's question:
A newborn child develops yellow skin every three days, and the doctor says it's an early onset of jaundice (usually occurring around day seven). I would like to ask the experts about the type and nature of this condition, whether it can be cured, and what potential consequences it may have. Please provide a comprehensive response. Thank you!Doctor's answer:
Hello, neonatal jaundice (hyperbilirubinemia) is caused by the accumulation of bilirubin (mostly unconjugated bilirubin) in the body. Its causes are complex, including both physiological and pathological factors. Some pathological jaundice can lead to central nervous system damage, resulting in bilirubin encephalopathy. Therefore, it is essential to strengthen clinical observation of neonatal jaundice, identify the cause as soon as possible, and provide timely treatment.[Characteristics of Bilirubin Metabolism in Newborns]
(1) Excessive Bilirubin Production
Newborns generate approximately 8.8 mg/kg of bilirubin daily, while adults produce only 3.8 mg/kg. The reasons are as follows:
- Fetal hypoxia leads to the production of a higher number of red blood cells, which are relatively excessive after birth and undergo more destruction.
- The half-life of fetal hemoglobin is short, and newborn red blood cells have a lifespan 20–40 days shorter than adults, shortening the bilirubin formation cycle.
- Other sources of bilirubin precursors are abundant, such as heme proteins from organs like the liver (e.g., catalase, cytochrome P450) and bilirubin precursors from ineffective hematopoiesis in the bone marrow (a small amount of red blood cells are destroyed during maturation).
(2) Insufficient Transport Capacity for Bilirubin
Newborns often have varying degrees of acidosis immediately after birth, which affects the binding of bilirubin to albumin in the blood. Preterm infants have lower albumin levels than full-term infants, both of which result in insufficient bilirubin transport capacity.
(3) Immature Liver Function
① Low Levels of Y and Z Proteins in Hepatocytes
Newborns have lower levels of Y and Z proteins required for bilirubin uptake in hepatocytes, which take 5–10 days to reach adult levels.
② Poor Conjugation of Bilirubin
The activity of uridine diphosphate glucuronosyltransferase (UDPGT) in hepatocytes is low and insufficient (only 0–30% of normal levels), making it unable to effectively conjugate lipid-soluble unconjugated bilirubin (indirect bilirubin) with glucuronic acid to form water-soluble conjugated bilirubin (direct bilirubin). This enzyme activity gradually normalizes after one week.
③ Poor Excretion of Conjugated Bilirubin
This makes it prone to biliary congestion.
(4) Characteristics of Enterohepatic Circulation
Newborn infants have fewer intestinal bacteria, which cannot reduce intestinal bilirubin to stercobilinogen or urobilinogen. Additionally, higher glucuronidase activity in the intestinal lumen hydrolyzes conjugated bilirubin into glucuronic acid and unconjugated bilirubin, which is then reabsorbed into the liver via the portal vein. Due to these characteristics, newborns’ ability to absorb, conjugate, and excrete bilirubin is only 1–2% of adults, making them highly susceptible to jaundice, especially when newborns are in states such as hunger, hypoxia, delayed meconium passage, dehydration, acidosis, cranial hematoma, or intracranial hemorrhage.
[Classification of Neonatal Jaundice]
(1) Physiological Jaundice
Due to the characteristics of bilirubin metabolism in newborns, approximately 50–60% of full-term infants and >80% of preterm infants develop jaundice within 2–3 days after birth, peaking on days 4–5. General condition is good, with jaundice typically resolving within 2 weeks in full-term infants and extending to 3–4 weeks in preterm infants.
Current upper limits for serum bilirubin levels previously used for physiological jaundice—full-term infants <205.2 μmol/L (12 mg/dL) and preterm infants <257 μmol/L (15 mg/dL)—have been questioned, as even smaller preterm infants with bilirubin levels <171 μmol/L (10 mg/dL) may develop bilirubin encephalopathy. Foreign countries have set the threshold for physiological jaundice in full-term infants at <220.59 μmol/L (12.9 mg/dL). Domestic scholars have found that the upper limit of bilirubin levels in normal full-term infants with physiological jaundice ranges between 205.2–256.5 μmol/L (12–15 mg/dL), with 31.3–48.5% exceeding the original 205.2 μmol/L. Similarly, 42.9% of preterm infants have serum bilirubin levels exceeding 256.2 μmol/L, prompting nationwide collaborative research to revise China’s diagnostic criteria for physiological jaundice.
(2) Pathological Jaundice
Pathological jaundice is characterized by:
① Jaundice appearing within 24 hours of birth
② Severe jaundice, with serum bilirubin levels >205.2–256.5 μmol/L or rising by >85 μmol/L (5 mg/dL) daily
③ Prolonged jaundice duration (full-term infants >2 weeks, preterm infants >4 weeks)
④ Jaundice recurrence after resolution
⑤ Serum conjugated bilirubin >26 μmol/L (1.5 mg/dL)
Active investigation of the cause is necessary for pathological jaundice. The main causes include:
1. Infectious
(1) Neonatal hepatitis: Most cases are caused by viral infections in utero, with cytomegalovirus being the most common. Others include hepatitis B, rubella, herpes simplex, coxsackie, EB virus, listeria, syphilis, and toxoplasma. Infection can be transmitted via the placenta or during delivery. Jaundice typically appears 1–3 weeks or later after birth, with pale or grayish stools, dark urine, and symptoms such as poor appetite and vomiting. The liver may be mildly to moderately enlarged.
(2) Neonatal sepsis.
2. Non-infectious
(1) Neonatal hemolytic disease
(2) Biliary atresia: This condition is primarily caused by in utero viral infections leading to postnatal progressive cholangitis, cholangiofibrosis, and biliary atresia; if the bile duct wall is weak, it may develop into a bile duct cyst. Jaundice typically appears 2 weeks after birth and worsens progressively. Stool color changes from yellow to white, the liver progressively enlarges with a hard and smooth edge, and liver function changes are mainly characterized by increased conjugated bilirubin. It may progress to cirrhosis after 3 months.
(3) Breast milk jaundice: Approximately 1% of breastfed infants develop breast milk jaundice, characterized by elevated unconjugated bilirubin without hemolysis. It often overlaps with physiological jaundice and persists without resolution, with serum bilirubin levels reaching as high as 342 μmol/L (20 mg/dL). Infants are generally well, and jaundice typically decreases after 4–12 weeks. No other causes of jaundice are identified. If jaundice decreases by 3 days after stopping breastfeeding, the diagnosis is confirmed. Current theories suggest that excessive β-glucuronidase activity in this type of breast milk increases intestinal reabsorption of bilirubin, while some researchers propose that the insufficient number of bacteria in the gut that convert bilirubin to urobilinogen and stercobilinogen is the cause.
(4) Hereditary diseases: G6PD deficiency is common in southern China, with a higher incidence of kernicterus. Other conditions include pyruvate kinase deficiency, spherocytosis, galactosemia, α1-antitrypsin deficiency, and cystic fibrosis.
(5) Drug-induced jaundice: Such as jaundice caused by drugs like vitamin K3, K4, and neomycin.